FluoGuide A/S
FLUO
Rank in Stocks
#22801
FluoGuide A/S is a Danish life science company dedicated to developing and... FluoGuide A/S is a Danish life science company dedicated to developing and commercializing advanced surgical solutions. Its flagship investigational compound, FG001, is currently undergoing Phase I/II clinical trials for the treatment of high-grade glioma (a type of brain cancer) and has also advanced to Phase II development for lung cancer. The company is further developing FG002, a preclinical-stage product that utilizes novel uPAR-targeted luminescent technology to enable surgeons to distinguish cancerous from healthy tissue during operations. FluoGuide A/S has established key collaborations, including an agreement with Linköping University Hospital to support the Phase I/II clinical evaluation of FG001 for the surgical removal of brain tumors, and an ongoing partnership with Copenhagen University Hospital. The company was founded in 2018 and maintains its headquarters in Copenhagen, Denmark.
Share Price
$3.03
Last synced: 2026-11-09
Market Cap
$49.54M
Change (1 day)
-1.40%
Change (1 year)
-37.69%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade FluoGuide A/S (FLUO)
Category
Healthcare
Operating Margin for FluoGuide A/S (FLUO)
Operating Margin as of November 2026 TTM: -89,779.29%
According to FluoGuide A/S's latest financial reports, its current operating margin (TTM) is -89,779.29%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for FluoGuide A/S from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -89,779.29% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -8,463.12% | -18.00% |
| 2023 | -10,321.28% | 1,986.29% |
| 2022 | -494.72% | 65.08% |
| 2021 | -299.69% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -100.00% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about FluoGuide A/S's operating margin
What is FluoGuide A/S's operating margin?
FluoGuide A/S's operating margin is -89,779.29%, as of Nov 2026.
What was FluoGuide A/S's operating margin in 2025?
In 2025, FluoGuide A/S's operating margin was 0.00%, compared with -8,463.12% in 2024.
How has FluoGuide A/S's operating margin changed since 2020?
From 2020 to 2025, FluoGuide A/S's operating margin was highest in 2025 (0.00%) and lowest in 2023 (-10,321.28%).
How does FluoGuide A/S's operating margin compare with similar companies?
FluoGuide A/S's operating margin (-89,779.29%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.